Pancreatic Cancer Research

ResearcherUniversity of TurkuNo recent work listed

Eija A. Korkeila

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5031195262. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 4

  1. Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Co-author DOI 10.1200/jco.22.01134↗
  2. Advanced pancreatic cancer - how to choose an adequate treatment option. Co-author DOI 10.3748/wjg.v21.i38.10709↗
  3. Disease outcome of patients with pancreatic cancer in a cohort treated outside clinical trials. Last author PMID 24324086↗
  4. [Pancreatic adenocarcinoma--a therapeutic challenge]. Co-author PMID 23087998↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heidi Koskela · 1 shared paper, 2013 · strength 0.06
  2. Miia Mokka · 1 shared paper, 2012 · strength 0.05
  3. Saila P. Kauhanen · 1 shared paper, 2012 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.